510(k) Report

510(k) · Cleared

Recalled · 2009

Synchron Systems Carbamazepine Test System

K955644510(k) TraditionalCleared Feb 16, 199666-day reviewClass II21 CFR 862.3645Recalls 4

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Instruments, Inc. · KLT Enzyme Immunoassay, Carbamazepine

Cleared on Feb 16, 1996 after a 66-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 1 later device descends from it. It has been recalled 4 times.

Decided
Feb 16, 1996
Review
66 days
Class
Class II
Product code
KLT
Recalls
4
Predicates
0

1 later device descends from it, 1 citing it directly.

Descendants, by year cleared 1997: 1 descendant cleared1995200020052010201520202025
  1. This deviceK955644 Synchron Systems Carbamazepine Test SystemBeckman Instruments, Inc. · 1996
  2. Descendant · cites it directly · 0 of its ownK971287 Synchron Systems Drug Calibration 3 PlusBeckman Instruments, Inc. · 1997

Most influential descendants

Showing 1 of 1 · See all
  • K971287Synchron Systems Drug Calibration 3 PlusBeckman Instruments, Inc. · 1997 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K955644Synchron Systems Carbamazepine Test SystemBeckman Instruments, Inc.1996—
+1K971287Synchron Systems Drug Calibration 3 PlusBeckman Instruments, Inc.1997—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199710
FIG. 1 — Lineage of K955644, 1996–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KLT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K971287Synchron Systems Drug Calibration 3 PlusBeckman Instruments, Inc.19970

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 11, 2009Not classifiedZ-1174-2012Nonconforming Material/ComponentThe recall was initiated because Beckman Coulter has confirmed reports of variability in results with the lots of Phenobarbital (PHE) reagent and calibrator.
Aug 11, 2009Not classifiedZ-1173-2012Nonconforming Material/ComponentThe recall was initiated because Beckman Coulter has confirmed reports of variability in results with the lots of Phenobarbital (PHE) reagent and calibrator.
Feb 19, 2009Not classifiedZ-2437-2010OtherThe reagent produces false low test results. Beckman Coulter has confirmed low recovery of values at the low end of the therapeutic range (<1.5 ug/mL, <3.13 umol/L) with SYNCHRON Systems Gentamicin Reagent (GEN) lot M804552. A false low…
Jun 11, 2003Not classifiedZ-0935-04OtherProduct was found to produce higher recoveries by about 7-12% compared to other lots.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K971287 (Beckman Instruments, Inc., 1997) has gone furthest, with 0 descendants of its own.

How does its category compare?

All KLT devices

KLT Enzyme Immunoassay, Carbamazepine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KLT

1in 2015

2007: 12011: 12013: 12015: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KLT

Too few KLT 510(k)s in any year since 2007 to give a median.

Recalls per year · KLT

1in 2013

2013: 1
2007high 1 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KLT

4in 2025

2009: 22010: 12011: 12012: 12013: 12014: 32015: 92016: 32017: 12018: 42019: 62020: 12021: 22022: 72023: 32024: 12025: 4
2007high 9 (2015) · low 0 (2007)2025

MAUDE reports naming product code KLT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—02
20100—01
20111—01
20120—01
20131—11
20140—03
20151—09
20160—03
20170—01
20180—04
20190—06
20200—01
20210—02
20220—07
20230—03
20240—01
20250—04
20260—0—
Cite this page

510(k) Report. “K955644: Synchron Systems Carbamazepine Test System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K955644

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026